GGrantIndex
← Search

MOLECULAR-TARGETED ADOPTIVE IMMUNE THERAPY FOR ERADICATION OF METASTATIC PROSTATE CANCER

$590,733FY2014Department of DefenseDOD

Virginia Commonwealth University, Richmond VA

Investigators

View source on USAspending →
MOLECULAR-TARGETED ADOPTIVE IMMUNE THERAPY FOR ERADICATION OF METASTATIC PROSTATE CANCER · GrantIndex